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PANORAMA
World Health: An Overview
Hiroshi Nakajima
I. What is the State of the Health of the Peoples of the World?
Life expectancy at birth: Changes in life expectancy at birth are rough
indicators of overall trends in health. For example, the World Health
Organization (WHO) reported that, worldwide, life expectancy rose
from 48 years in 1955 to 66 years in 1997 and 1998. These statistics are
averages based on actuarial tables in which it is assumed that the death
rate at every age in a population during a given year will be experi-
enced by the babies born in that year for the duration of their lives. Life
tables have tended to underestimate life expectancy because they fail
to account for economic, social, and technological development. How-
ever, public health gains are fragile, and global statistics are heavily
affected by developments in China and India, which together account
for over one-third of the world population. Life expectancy has
declined over the past decade in parts of Africa hard hit by HIV/AIDS,
and from 1991–94 in the former Soviet Union. Life tables are calculated
from vital statistics (birth and death registrations) and census data
which, although often poor, are recorded in all countries.
Life expectancy at birth increased significantly in the twentieth cen-
tury, primarily through spectacular gains in infant and child survival.
The two main reasons are:
(1) Improvement in and spread of technology and public hygiene
(better nutrition, safer water and food, waste disposal and sewage
treatment, antiseptics, and preventive and curative drugs and vac-
cines).
(2) Improvement in the educational level and social status of women.
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Health for All: In 1978, the member states of the World Health Organi-
zation set three targets to be achieved by the year 2000. This is termed
“Health for All.”
(1) Life expectancy at birth above 60 years in all countries
By 1995, this target had been achieved by countries representing 86
percent of the world population.
(2) Under-5 mortality rate below 70 per 1,000 live births in all countries
By 1995, this target had been achieved by countries representing 64
percent of the world population.
(3) Infant mortality rate below 50 per 1,000 live births in all countries
By 1995, this target had been achieved by countries representing 60
percent of the world population.
The shortfalls in these targets show that there is still much room to
reduce infant and child mortality. Whole nations are falling short, and
these data, which are averages, mask high death rates in poor and
socially marginalized groups within countries that have achieved the
national targets. Some wealthy countries (and Cuba) have achieved
under-5 mortality rates of 3–9 per 1,000, close to the current technolog-
ical limit.
Extending life expectancy: Extending life expectancy, already 75 – 80
years in the developed world, is running into the relentless arithmetic
of the Life table where the easy gains have been achieved. For exam-
ple, it takes a 9 percent reduction in the death rate at each age to move
the average from 80 to 81 years. Biodemographers estimate that the
maximum average life expectancy with current medical science is
about 85 years. Substantial increases above that age may await medical
breakthroughs that attack the aging process, for which there is ample
possibility, given the pace of research in human genetics. (Natural
selection, of course, favors reproduction over longevity.) Some, includ-
ing me, question whether adding years to life expectancy above eighty
is an appropriate goal for societies (individuals should be free to pur-
sue longevity as a personal goal), especially if extension of the life-span
is accompanied by disability, suffering, and dependence.
Alternative measures such as “health expectancy,” “disability-
adjusted life expectancy” (DALE), or “disability-adjusted life years”
(DALYs) have been tried in recent years by the World Bank, Harvard
University, and others. They are composites of morbidity and mortal-
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ity statistics that are conceptually problematical and pose challenges in
defining and collecting data, and obtaining international comparabil-
ity. None has yet rallied a consensus in the scientific community or
among public health policymakers. DALYs are nearly useless as policy
tools in developing countries. Some analysts have turned to the “Del-
phi” method, or estimates by structured panels of experts or “key
informants” (of their choosing), to fill gaps or correct deficiencies in
statistics or even substitute for them. These estimates also are often
widely off the mark. Nonetheless, a focus on disability as well as mor-
tality is appropriate in today’s health promotion strategies because
non-fatal, disabling mental and physical illnesses and injuries, which
are widespread and devastating, are not picked up well in mortality
statistics.
The explosion of centenarians: The number of centenarians has been dou-
bling every decade since the 1950s in wealthy countries and doubled in
China in the 1980s to more than six thousand, now the largest number
in a single country. Their absolute number is small, with women out-
numbering men four to one, but their presence, wisdom, and problems
give us a glimpse of how a second demographic transition might look,
assuming continued decline in fertility, with the population pyramid
turned upside down! (Many new aids for sight, hearing, and mobility
are coming onto the market.) Population aging, combined with declin-
ing fertility, has created a global financial crisis in health care, affecting
even the wealthiest societies. Health care costs for people over 65 are
five times greater than for younger persons.
Causes of death: In 1998, there were about 54 million deaths in a global
population of nearly six billion. Causes of mortality often are poorly
identified, and data must be interpreted with caution. The continuing
toll of communicable diseases (see Table) reflects the twentieth cen-
tury’s uncompleted health revolution. The preponderance of deaths
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Causes of Death 1998 %
Communicable diseases, maternal, 
perinatal and nutritional causes 30
Noncommunicable diseases 60
Accidents and injuries 10
Source: World Health Report 1999 
from noncommunicable conditions (heart and lung diseases, cancer,
diabetes, etc.) measures achievements in child survival, which, how-
ever, have left many developing countries struggling with a “double
burden” of disease and investment in treatment and care of large num-
bers of chronically ill or disabled middle-aged and elderly citizens at a
time when they are still battling rather high child mortality and need
to reduce inequality in infrastructure and health service for disadvan-
taged groups. Advances in molecular biology have revealed that many
cancers are, in part, an expression of chronic infection — interlinked
with environmental, nutritional, lifestyle, and genetic influences. The
traditional distinction between communicable and noncommunicable
diseases is becoming blurred.
Tobacco: Tobacco is the major preventable cause of death from noncom-
municable disease, directly accounting for about four million deaths
annually. The WHO and the international health community have
been developing and debating the idea of a global framework conven-
tion on tobacco control (FCTC) for about ten years. I advocated this
myself. The FCTC is now under negotiation just as the industry has
begun to embrace regulation to protect itself from lawsuits. There is a
risk that a weak convention might protect the industry from legal lia-
bility while doing little to constrain it from advertising, sports sponsor-
ship, etc. It is an idea that had better prospects under a Democratic
administration in the United States.
Age at death: Age at death also points to the unfinished health revolu-
tion of the twentieth century. Forty percent of deaths under age fifty
(see Table), and, especially, twenty percent under age five (more than
ten million in actual numbers), represent premature and preventable
deaths. Most occur in the forty-nine least developed countries where
per capita public expenditure on health is less than $10 per year and
where three of four people still die under age fifty. A global average
immunization rate of 80 percent for six childhood diseases, which are
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Age at Death 1998 %
under 5 20
5-50 20
over 50 60
Source: World Health Report 1999
major killers, was achieved in 1990 and has been maintained or slightly
improved in succeeding years, but immunization rates among disad-
vantaged populations and in areas of instability are poor and fluctuate
from year to year, often depending on truces and external vaccination
initiatives.
Communicable diseases (old and new): While some 70 percent of the
world’s population eventually dies from chronic, noncommunicable
conditions or injuries, infectious diseases are the leading cause of pre-
mature death. Their impact is heaviest on the one billion poorest peo-
ple on the planet (concentrated in Africa and South Asia). The Table
below features the main causes of this 30 percent of deaths. In the past
25 years, along with HIV/AIDS, some thirty infectious diseases have
emerged (Ebola and other hemorrhagic fevers, hepatitis C,D,E. . . , BSE,
Legionnaire’s disease, Hantaan virus, etc.) or reemerged (tuberculosis,
cholera, and malaria) where they had been unknown for years to shake
any complacency that infectious diseases are being brought under con-
trol. Increasing microbial resistance (multidrug-resistant malaria,
cholera, pneumonia and TB, and hospital infections) and new prob-
lems with food safety (diseases in meat animals and E. coli 0157:H7)
have intensified these concerns.
IMCI: Of the ten million deaths annually of children under five noted
above, over 70 percent are caused by diarrhea, pneumonia, measles,
malaria, malnutrition, or a combination of these. Many children are
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Mortality from major communicable diseases and
maternal, perinatal and nutritional conditions 1998
Respiratory infections 21%
AIDS 14%
Perinatal conditions 13%
Diarrhoeal diseases 13%
Childhood diseases 10%
(measles: 5%)
Tuberculosis (HIV-neg.) 9%
Malaria 7%
Maternal conditions 3%
Nutritional conditions 3%
(all other: 7%)
Source: World Health Report 1999
lost because parents and first-level health workers confuse similar
symptoms of these afflictions or fail to recognize that the child is suf-
fering from more than one of them. In 1992, WHO and UNICEF
worked out step-by-step clinical guidelines to integrate all five condi-
tions in case management, called “Integrated Management of Child-
hood Illness” (IMCI). The strategy requires reliable supplies of oral
rehydration salts, appropriate antibiotics and antimalarials, and nutri-
tional support. In 1994 – 95, WHO and UNICEF pretested this strategy
in Kenya, the Gambia, and Ethiopia with promising and cost-effective
results. It is now being adapted to the specific conditions of many
other countries.
Essential drugs: Procuring and distributing the most effective mix of
drugs and vaccines at the least cost is a major task of health systems. In
the 1970s, WHO developed a minimum list of essential drugs (about
300), frequently updated and modified to specific country needs, and
with donor funds procured drugs on a bid basis for health services in
developing countries. Whenever possible, the cheapest generic or off-
patent version of a drug is recommended, and donations of drugs from
manufacturers are constantly solicited. Normally these activities
attract little public attention. The recent widely publicized issue con-
cerning the provision of antiretrovirals and other drugs to HIV/AIDS
patients in Africa is unusual in that activist groups in the developed
world are pressing manufacturers to lower prices of patented drugs
which currently sell at premium prices in their home countries. The
manufacturers believe they need high profit margins to successfully
maintain research and development activities.
Tuberculosis (TB): When the resurgence of tuberculosis was identified
in 1989–90, WHO adapted and promoted the DOT (Directly Observed
Therapy, which means that a health worker personally observes the
patient taking the cocktail of antibiotics that has to be ingested daily
for 6–8 months to obtain a cure) strategy, which produces a 90 percent
or better cure rate when successfully applied. Currently, less than half
of TB patients in the world have access to DOT. Equally important is
diagnosis by microscopic examination of sputum and sustained avail-
ability of appropriate TB drugs. Recent studies indicate that the key to
success in DOT is intensive contact and follow-up with the patient
rather than DOT per se. HIV/AIDS patients often contract TB as an
opportunistic infection. Curing HIV-positive patients of TB is a special
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challenge. There is a high risk of developing resistant microbes and
spreading them to the non-HIV-infected population.
Malaria: WHO efforts to eradicate malaria in the 1950s and 1960s failed
because of resistance to DDT (which also had unfavorable environ-
mental consequences) and to the common anti-malaria drugs chloro-
quine and fansidar. Malaria was, nonetheless, contained for many
years. It began to spread again in the 1980s, possibly due to climate
change and population movements associated with economic develop-
ment (especially exploitation of tropical forests) and with migration
out of conflict zones where public health activities had been aban-
doned. At a 1992 ministerial conference, WHO formally abandoned
the eradication strategy in favor of one that integrates malaria control
into the health care system with surveillance, including patterns of
resistance, use of mosquito nets treated with insecticide, selective
household and community spraying (and clean-up of potential mos-
quito breeding sites), early detection and treatment (especially of chil-
dren), use of new drugs where resistance has developed, and
systematic prophylaxis for pregnant women. In 1997, WHO launched
a Multilateral Initiative on Malaria (MIM) in Africa involving three
international agencies and six bilateral donors with twenty African
countries. The 1992 guidelines and MIM are now incorporated into
WHO’s Roll Back Malaria campaign.
Epidemiological transition profiled: Many middle-aged and older people
today, particularly in Asia and Latin America, of which I am one,
belong to a generation that experienced simultaneous epidemiological
and demographic transitions. Born with a life expectancy of around
fifty, many migrated from the countryside to one of the crowded, pol-
luted cities now inhabited by 50 percent of the global population after
surviving several pre-transitional diseases, injuries, and nutritional
deficiencies in childhood. Modestly rising income from hazardous,
stressful employment and a modern lifestyle led them to consume
increasing amounts of sugar, alcohol, fat, salt, and tobacco. They and
their working spouses had little opportunity for sports and exercise
and lived in housing unkindly compared to rabbit hutches. They had
half as many children as their parents, benefiting from some family
planning and obstetrical services, and spent most of their discretionary
income on children’s education. Members of this transitional genera-
tion often live beyond 65, coping with multiple chronic diseases, dis-
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abilities, and dysfunctions (loss of teeth, hearing, and eyesight, back
pain, diabetes, pulmonary and cardiovascular disease, cancer, etc.).
They care for grandchildren and do casual work as long as physically
able in order to supplement meager savings and retirement benefits.
Women outlive men by a few years in sickness and disability.
II. Does this Age of Globalization Help or Hinder the 
Quality of Life and Health?
Globalization is not a very rigorous concept, and it needs a political
project. I see the term as shorthand for the interaction of a number of
developments in the late twentieth century, focused around the link-
ing and deregulation of markets, transport, and communications. Pop-
ulation growth, environmental degradation, and progress in medical
science, although not particularly aspects of globalization, are impor-
tant in the health sector.
(1) The communist world collapsed spectacularly, breaking down the
barriers to trade, travel, and communications represented by the
“iron curtain.” But the end of the Cold War also generated social
turmoil, wars, and millions of refugees. Western countries, espe-
cially the United States, saw in this a universal triumph of their
values.
(2) Newcomers (ex-communist and ex-Asian tigers) joined the ranks
of the insolvent under IMF/World Bank tutelage, and the chorus
for debt relief finally achieved some results.
(3) Information/communication technology discovered as far back as
the 1960s reached commercialization in affordable, user-friendly,
and globally interconnected packages. This included continuous,
real-time television news (too often with shallow, inaccurate, and
culturally insensitive reporting on health issues) followed by the
Internet, which widened the choice of information sources for
those with access, including health professionals.
(4) International air travel came within the reach of millions, as new
roads (often aid-funded) linked remote areas to the outside world,
pushing back wilderness and bringing the growing human popu-
lation of the planet into closer contact with each other and with
insects and wild animals, just as climate changes were altering dis-
ease patterns.
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(5) The Uruguay round of trade negotiations culminated in the estab-
lishment of the World Trade Organization (WTO), which is
intended to have more institutional power, a broader mandate to
liberalize and expand world trade, including health services and
patent-protected pharmaceuticals, and a more inclusive member-
ship (China, Russia, etc.) than the previous regime.
Health values: The modern health professions, derived from Western
medicine, share a value system based on scientific rigor and respect for
human dignity and the rule of law, originating in the Hippocratic oath.
The discrediting of the Soviet model was a vindication of these values
which, nonetheless, need to be constantly reaffirmed, particularly as
possibilities for cloning and other genetic manipulation increase. But
we must acknowledge the public health achievements of states like
China, Malaysia, Singapore, Cuba, and Iran. While the rest of the
world shares many Western values, it does not fully embrace the
Anglo-Saxon market model. The ending of the Cold War on Western
terms was favorable, however, to an ongoing global trend toward
greater market orientation in the health sector as a means of control-
ling the costs of serving a growing and aging population. Evaluation of
health care has become pragmatic and results driven. But public health
never gets the attention it deserves. The relationships between health
and political and economic systems, development, and poverty are
complex and far from fully understood.
Health as a Priority: IMF/World Bank structural adjustment policies
forced poor countries to cut already inadequate health expenditures
and charge user fees in order to repay debt. Many developing coun-
tries hurt their cause, however, by spending the bulk of their health
budgets on hospitals, which liberal economists consider to be candi-
dates for privatization, rather than on primary health care in commu-
nities. Creditor countries, including the United States, which control
the policies of the World Bank and IMF, have recently taken steps to
forgive debt conditionally and to recognize health as an investment
rather than a consumption expenditure. If this sticks, it is an important
shift.
Information technology: Information technology as it is developing is a
superb set of tools for medical research and practice. Innovations rang-
ing from DNA chips to so-called “hospitals without film” are revolu-
Hiroshi Nakajima
11
tionizing health care. Digitalized X-rays, scans, or ultrasound images
can be transmitted to the next room or around the world together with
text, laboratory slides, and data from a patient’s computerized chart
while practitioners consult in real time, looking at the same informa-
tion on their screens. The world of medical specialists who used to
meet every year or two at a conference has shrunk to the point that the
main constraints on communication and the sharing of knowledge are
time and time zones. Personal trust and confidence remain critical.
Medical mistakes linked to Internet use are a risk, and serious issues of
liability and protecting the confidentiality of patient records are loom-
ing.
Patients themselves will increasingly be able to avail themselves of
consultations with health professionals via tele-medical services. Heart
pacemakers have long been adjustable by telephone, and new telecom-
munications offer much more sophisticated monitoring of patients at
home. Through tele-medicine, patients will have a choice between the
knowledge and opinions of leading specialists or low cost medical con-
sultations within a limited health care budget. A savvy health con-
sumer already has an enormous reach of medical and health
information online but must filter it. A substantial, for the most part
unregulated, market has developed via the Internet for medicines and
health products, but the goods themselves are subject to national trade
regimes. The failure and discrediting of many online sales schemes is a
cautionary tale.
Trickle down: The Internet is an important health resource for the mid-
dle and upper classes and health professionals in developing coun-
tries, especially English-speaking South Africa, India, and ASEAN
nations, which are already deeply involved in the global information
market. China, with its 1.3 billion population, will develop a parallel
Chinese language Internet. Digitalized telecommunications, particu-
larly via wireless telephones, offer catch-up potential for poor and
remote populations. In the health sector, they will need specialized
applications, probably requiring public investment, to bridge the digi-
tal divide. It may be an apocryphal story, but it is said that Bill Gates
initially wanted to tie his health philanthropy for the poor to informa-
tion technology but found it unfeasible and turned to conventional
health interventions.
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WTO: Health services in which government intervention is significant
have lagged behind others in WTO negotiations on liberalizing trade
in services (GATS), with less than 40 percent of members making any
commitments in the Uruguay Round (compared with 70 percent in
finance and telecommunications). In many cases, governments are
conceding what they are unable to control (tele-health services, infor-
mation, and medical care abroad for patients who have the funds or
rare portable health insurance benefits). Portable health insurance for
patients and liberalized investment regimes for international hospital
chains would enable developing countries to offer price-competitive
hospital care to patients from abroad.
The WTO and the Internet are driving the standardization of med-
ical education and health care procedures (reducing national and local
idiosyncracies) around the concept of “evidence-based medicine” and
with it the standardization of professional qualifications, licensing
examinations, and so on. Globalization of the health labor market is
already well underway with increasing opportunities, competition,
migration, and Third World brain drain. Tele-teaching would poten-
tially enable health professionals to upgrade/update their knowledge
wherever they live.
Health and Travel: Travel has been spreading knowledge, culture, and
disease for many centuries. Travel and migration have been especially
important in spreading sexually transmitted diseases, including AIDS.
(The Japanese have a proverb: “There’s no shame on a trip.”) The
world has over 5,000 airports, all linked to land and water transport
networks. Today, no two permanently inhabited places on the globe
are more than a few days apart.
A few years ago, a German economic minister developed a nearly
fatal case of cerebral malaria after visiting Africa, but he didn’t contract
it in Africa, where all necessary precautions had been taken. Instead, it
was from infected mosquitoes that flew out of his plane’s baggage
compartment upon the minister’s arrival back in Germany. There are
hundreds of cases of airport malaria every year, and Americans are
familiar with the West Nile virus threatening New York City. Doctors
often misdiagnose travelers who bring home exotic diseases, but in
parallel with increased trade and travel, disease surveillance and con-
tainment have also improved. In the mid-1990s, WHO, for example,
went online with its computerized surveillance services for disease
outbreaks and microbial drug resistance. With user-friendly, standard-
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ized software, laboratories around the world that collaborate with
WHO are able to merge their files and monitor, analyze, and exchange
data online. Patterns can be spotted and action taken quickly. The out-
put is even available online to the public. The 1976 outbreak of Ebola in
former Zaire ran its course unnoticed by the outside world. In 1995,
WHO had a team on site (barely ahead of the media) within 2 – 3 days
of confirmation. With globalization, disease can spread faster, but out-
breaks can be signaled and help can arrive faster. Disease surveillance
and control is a public good. Making the necessary investment to keep
pace requires leadership and political will.
Trade: Food and medicines have always occupied a special place in
economic and trade regulation. The phytosanitary norms applied by
the WTO are in the Codex Alimentarius produced jointly by WHO and
the U.N. Food and Agriculture Organization. There is always tension
between facilitating trade and protecting human health. Politically,
agricultural interests are strong and health interests weak (and domi-
nated by doctors who focus on cure rather than prevention). Recent
experience with deleterious health effects from genetically-modified
corn and outbreaks of Mad Cow Disease and Foot and Mouth Disease
in Europe are cautionary tales about market deregulation and industri-
alized agriculture for export. The pendulum may be swinging away a
bit from deregulation toward the principle of health precaution.
Freeing markets may increase efficiency and wealth in the aggre-
gate, but there are winners and losers. Income distribution has wors-
ened through years of global trade expansion. The gap between the
rich and poor is widening both between and within countries, and the
absolute number of people living in poverty is increasing. In the face of
these trends, the public health gains of the past half-century are at risk
of unraveling. Globalization needs a political project to give it a human
face, to make it work for the poorest one billion people on the planet.
In the decade of the 1990s, U.N.-sponsored ministerial and summit
conferences on the environment, children, women, population,
malaria, nutrition, AIDS, poverty, housing, and human rights identi-
fied problems and established consensus goals and strategies for their
alleviation. There has been enough talk. Activists should use the inter-
national political and moral authority of these goals to go to work
country-by-country, village-by-village, goal-by-goal to achieve them.
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III. What are the Roles for Science and Culture in the Promotion 
of Health and the Treatment or Eradication of Disease?
Neither science nor culture nor the two together will do much to
improve human health without finance. Money is a scarce resource.
The United Nations technical agencies, including WHO, were set up
as global normative institutions. Their early focus was on science and
statistics. The founding fathers of the U.N. believed they could achieve
U.N.-centered global peace and security, and that this would automat-
ically unleash the forces of prosperity. When none of this happened,
U.N. agencies began giving technical and policy assistance to less
developed countries and suggesting global priorities. This work
increasingly interacted with politics and culture. In WHO, “vertical
programs” attacking specific diseases or needs (yaws, smallpox,
malaria, polio, leprosy, essential drugs, training, etc.) worldwide were
launched with varying results. Those experiences gave rise to the Pri-
mary Health Care movement for a minimum set of health services for
all in a context of social development (education, public infrastructure,
etc.) linked to achieving the HFA targets mentioned above. Primary
health care action in countries had to be adapted to local conditions
and culture. Sometimes health messages — for example, AIDS preven-
tion and the movement against female genital mutilation — have to
promote cultural change, which requires careful research and prepara-
tion.
Female literacy: In large regression studies across developing countries,
gains in adult female literacy, more than increases in income, explain
reduction in fertility, under-5 mortality, and adult female mortality.
The results of these regression studies were surprising in that they
went against the conventional wisdom that economic development
with increasing per capita income is the best way to lower fertility and
mortality. For both women and men, gains in female literacy con-
tribute more than gains in income and nearly as much as increases in
the use of new knowledge toward achieving all three HFA targets. (In
1995, about 70 percent of all women on the planet were literate.)
Throughout the world, women overwhelmingly manage family
hygiene, nutrition, child rearing, and their own fertility. A woman
who can read and apply new knowledge has the tools to make a criti-
cal difference in family health, including the health of the adult males.
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Health education: Given the complementarity of health and education,
WHO programs and guidelines emphasize health education and
health services in schools. They include important efforts to train
teachers of health education and student counselors who must be con-
vinced to set an example of what they teach. Similarly, effective health
education requires that schools set a healthy example in sanitation,
safety, school lunches, sports, and so on. The importance of peer influ-
ence in the educational process is now recognized, and health educa-
tion has to be designed to enable students to learn from and reinforce
each other. In societies where adult women are secluded in the family
home, a few years of childhood schooling offer the best chance to
impart basic health knowledge and motivation. In these societies, male
relatives rather than mothers usually accompany children to receive
health care. It poses a challenge to recast health messages intended for
mothers to impact on a grandfather or a brother barely older than the
child.
Life-cycle approach: The profile described above of the generation of the
epidemiological transition is one of people who had rudimentary
health education in school and none relevant to noncommunicable dis-
eases. Health promotion and education have to change to cover
lifestyle and incorporate a life-cycle approach so that healthy behavior
and timely health monitoring at each stage in life, starting with the
pre-pregnancy counseling of the mother, enable a person to better live
each succeeding stage. This is called “positive health” and “active
aging.” Molecular biology and genomic information are revolutioniz-
ing health monitoring and disease prevention at a price. AIDS-preven-
tion, anti-smoking, physical fitness, and safe driving efforts, to name
some examples, must impart inner discipline and a long time-horizon
to individuals. As health promotion and disease prevention increas-
ingly rely on motivating individuals to preserve their own health, the
spiritual dimension has assumed greater importance. Organizations
with a spiritual core, excluding cults and fanaticism, are often the most
effective in helping individuals to avoid or overcome addictions,
stress, or a propensity to violence, and to live constructively with long
term treatments and chronic illness.
HIV/AIDS: I appreciate the analysis of Professor Ronald Bayer con-
cerning “AIDS exceptionalism,” which has certainly characterized the
international response. AIDS is the only disease ever to have its own
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United Nations agency (UNAIDS), or, more correctly, the U.N.’s first
seven-agency co-sponsored program, which, fortuitously, has become
a vehicle for U.N. Secretary-General Annan to intervene personally in
the AIDS crisis. Concentrated most acutely in Africa, the AIDS epi-
demic needs an African of his stature to galvanize the global response
and to speak frankly to Africans on difficult issues involving beliefs
and cultural practices.
When the AIDS virus was identified, I was in Manila as Director of
the Western Pacific region of WHO, where several countries had large
émigré populations on the U.S. west coast, hosted U.S. military facili-
ties, tolerated all varieties of sex tourism and/or were asked to provide
HIV-negative certificates to contract workers in the Middle East. Lead-
ers in the region clamored for technical assistance on AIDS, and I had
to start a regional AIDS program to meet this legitimate demand
although my initiative was not well-received by the WHO headquar-
ters AIDS program, the Global Program on AIDS (GPA), the predeces-
sor to UNAIDS. Indeed, in 1987, we discovered several dozen
HIV-positive prostitutes near U.S. bases in the Philippines and HIV-
positive donated blood in the South Pacific islands.
After I became Director-General of WHO in 1988, I worked hard to
decentralize the GPA (entirely in Geneva, at the time, in a building
they had built for themselves), move it into the field, and integrate it
with public health programs on other sexually-transmitted diseases.
The GPA had a shortage of qualified personnel as many of the early
recruits were non-technical journalists, writers, public relations spe-
cialists, social scientists, human rights activists, diplomats, etc., who
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HIV/AIDS through 2000 
Living with HIV/AIDS 36.1 million
(Africa 25.3 million)
Died 21.8 million
(Africa 16.4 million)
Total infected 57.9 million
(Africa 41.7 million)
HIV/AIDS in 2000
New infections 5.3 million
(Africa 3.8 million)
Died .3 million
(Africa 2.4 million)
were quite successful with media and opinion in the West but had
much difficulty in the field. By the mid-1990s, however, the GPA had
developed programs and partnerships with national AIDS programs
in over 150 countries.
Uganda: There were some success stories in HIV prevention with the
GPA in Africa, notably Uganda, where WHO coordinated a program
involving over 100 organizations, which halved the rate of infection
from around 20 percent of the sexually active population. Field
research showed that girls were becoming infected as early as age 11.
Adolescent girls, 15 – 19, had five times the infection rate of boys that
age, and young women, 20 – 24, double the rate of their male peers. It
was clear that adolescent girls were contracting HIV from older
infected men at puberty and earlier. A successful intervention to pre-
vent AIDS needed to reduce the vulnerability of women and change
the sexual behavior of men, and it needed to reach children as young
as the 6–10 age group in a country where only half the school age chil-
dren were in school. President Yoweri Museveni was the first African
head of state to address AIDS proactively, initiating not only targeted
educational campaigns, voluntary HIV/STD testing, and social mar-
keting of condoms but also action to change the norms and values of
society. As confidence in the commitment of the political leadership
and its performance grew — and this is critical — funding increased
from $500,000 (1989) to over $30 million per year where it remained. In
1997, Uganda (population 20 million) received 20 percent of AIDS pre-
vention aid to Africa. It is the first African country to turn around its
AIDS epidemic. Similar conditions of HIV transmission exist in other
African countries, and with strong funding and political commitment,
similar results probably could be achieved. Thus far, most AIDS pre-
vention in Africa has been on the scale of demonstration projects.
Thailand: A contrasting success story is that of Thailand where com-
mercial sex and intravenous drugs were a lethal combination for
spreading HIV. Thai society historically has been tolerant of prostitu-
tion (although it is illegal) and stable polygamy, and hostile to casual
sex, which is viewed as socially disruptive. Widespread prostitution
and drug addiction were the basis for sex tourism organized by crimi-
nal syndicates which brought HIV/AIDS to Thailand where about a
million people became infected, one of the highest rates in the region.
An intensive campaign for 100 percent condom use in commercial sex
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transactions has more than halved the sero-prevalence rate among
young Thai men.
Recent AIDS initiatives: Briefly, I think the health emergency provision
in the WTO TRIPS agreement should be used to lower prices and
increase the supply of antiretrovirals and other drugs needed in Africa.
This is why the emergency provision was included in the agreement,
and using it successfully will show WTO’s human face. I do not
believe that patent holders will donate or cheaply supply sufficient
quantities of drugs to meet the needs of more than a few percent of the
people in need. Ultimately, external funding will fall short of the goals
being set, which already do not cover the needs. I contend that this ini-
tiative will develop case-by-case with many approaches and that nei-
ther the U.N. nor the World Bank will control it. The best work
international health agencies might do is to help countries define their
needs, formulate requests, and find partners, and then document out-
comes, employing technically rigorous standards, to develop and cir-
culate a repertory of success/failure stories, lessons learned, and best
practices. Monitoring microbial resistance, for which evidence is
mounting, is very important as is funding of research for a vaccine,
which is still the best hope of mastering HIV/AIDS.
IV. What Roles are Appropriate for Governments, 
IGOs, NGOs, and the Private Sector?
Comparative advantage: The international community uses the (Ricar-
dian sounding) term “comparative advantage” to define roles of pub-
lic and private actors in global issues. Examples in the health sector
are:
Governments: All matters where national sovereignty counts — legisla-
tion and legally enforceable norms and standards (including domestic
enforcement of international health regulations), vital statistics, licens-
ing, patents, trade regulation, immigration, quarantine, bilateral and
multilateral ODA (donors and recipients), domestic public health pol-
icy and action (especially disease surveillance and control), public
infrastructure, basic education, participation in IGO meetings, and
negotiations and implementation of resulting resolutions and agree-
ments.
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IGOs:
World Bank/IMF: (donor control) Multilateral funding, large-scale
lending and project coordination and implementation, financial man-
agement, macro research and policy advice and pressure. Counterpart
to finance ministry in governments.
U.N. system: (one country/one vote) Consensus building and advo-
cacy for global commitments and priorities, global technical norms
and standards, statistics and surveillance (including of compliance
with international health regulations), technical and policy assistance
to developing countries, donor and partner search and coordination,
research, feasibility studies, special programs (voluntary contributions
controlled by donors) where donor governments prefer multilateral
action (family planning, research on tropical diseases and contracep-
tion, refugee programs, procurement of essential drugs, training, etc.).
Counterpart of foreign ministry and functional ministries in govern-
ments.
NGOs: Advocacy, activism, political mobilization and influence, and
fundraising (private and government sources) from global to local
level. Formal and informal representation with governments and IGOs
and at IGO conferences. Self-generated field activities and contracts
with governments and IGOs for specific activities. Counterpart of civil
society. The term “GONGO” (government-organized NGO) has
appeared in parts of Eastern Europe where statist attitudes continue to
hold sway.
Private Sector:
Firms: Profit-making contractors for goods and services, sources of
monetary contributions and donations in kind (drugs, vehicles, and
equipment), often in response to tax incentives, lobbyists for company
interests on health issues (drug policy, infant formula, tobacco, etc.).
Philanthropic Business Organizations and Foundations: Sources of
funds and volunteers, i.e., Rotary International contributions to polio
eradication and Sasakawa Foundation contributions to smallpox and
leprosy programs.
Industry Associations: Lobbyists for industry interests on health
issues.
Tobacco, Pharmaceuticals, and Infant Formula: WHO uses the expres-
sion “tobacco or health” and has a publicly adversarial relationship
with tobacco manufacturers. WHO guidelines on infant formula,
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which it calls “breast milk substitutes,” oppose advertising and dona-
tions which would discourage mothers from breastfeeding. However,
HIV transmission via breast milk is imposing limited exceptions to this
position. WHO is in both conflict (patents and pricing) and coopera-
tion (drug donations and essential drug procurement for developing
countries) with the pharmaceutical industry. WHO has strict guide-
lines on drug donations, especially for humanitarian emergencies,
because many donations in the past have been unmarketable products
donated for tax write-offs, which encumbered relief operations. All
manufacturing sectors that supply products affecting human health
face growing pressures for more socially responsible behavior. Phar-
maceutical and tobacco manufacturers may eventually come to prefer
regulation to endless attacks on their interests and open-ended harass-
ment from media and public interest groups.
V. Conclusion: Problems and Issues for the Future
Coordination, especially in the field, of a large number of partners,
each with its own governance, agenda, organizational culture, and
funding, is difficult and sometimes poor even when there is formal
consensus on principles and action. (Many U.N. consensus documents
paper over disagreements that reemerge in the field.) In the end, con-
trol over funds determines control over activities.
Governments are hostile to NGOs that are friendly to political oppo-
sition or dissident groups. Some NGOs are openly or secretly financed
by foreign governments and suspected of subversive or intelligence
activities. Others financed by the private sector have hidden agendas
to market products or promote special interests.
Governments are sometimes unwilling or unable to honor their
obligations under international agreements. For example, in 1994, the
Indian government, which hosts the WHO regional office covering
that part of the world, refused to fulfill its obligation under the interna-
tional health regulations to notify WHO of an outbreak of pneumonic
plague in Surat. A request to investigate by countries of the neighbor-
ing region, which had already begun to impose travel and trade
restrictions in response to sensational media stories and rumors, pro-
vided WHO with a belated constitutional mandate to act. Much of the
economic harm from this rather small incident could have been
avoided if the Indian government had been more transparent and
lived up to its international obligations.
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There is heavy competition for turf, funds, media coverage, and
public recognition among all international health partners. Some of
this is good, but it leads to exaggerated claims of success, excessive
expenditure on public relations, and high fundraising and overhead
costs. At the other extreme, partnerships can lead to collusion and cor-
ruption when financial oversight is weak.
Global priorities painstakingly agreed upon in U.N. institutions eas-
ily become distorted or unravel when pressure groups and private sec-
tor interests in donor countries are driving policy. A current example
is the response to AIDS in Africa.
All U.N. system agencies have had zero nominal growth budgets
for a number of years, reflecting the policy of the United States but
silently supported by the majority who also wish to hold down costs to
themselves. Unlike the U.N. itself, the technical agencies, including
WHO, did not benefit from a personal donation by Ted Turner when
the U.S. share of their budgets was reduced. They have to make up the
shortfall from miscellaneous income, mainly interest on money in the
pipeline for field activities, which formerly was available for high pri-
ority activities. Voluntary contributions, now in the majority, reflect
the interests and priorities of donors and absorb administrative funds
from the regular budget. The one country/one vote element of the
international system is weakening. 
Bibliography
Adlung, Rudolf, and Antonia Carzaniga. “Health Services under the General Agreement
on Trade in Services.” Bulletin of the World Health Organization 79, no. 4. Geneva, 2001.
Attaran, Amir, and Jeffrey Sachs. “Defining and Refining International Donor Support
for Combating the AIDS Pandemic.” The Lancet 357 (2001): 57–61.
Bursaux, Elisabeth. “L’augmentation de l’ésperance de vie marque le pas.” Le Monde, 21
February 2001.
Epstein, Helen. “Time of Indifference.” New York Review of Books, 12 April 2001.
General Accounting Office. “U.S. Agency for International Development Fights AIDS in
Africa, but Better Data Needed to Measure Impact.” GAO-01-449. Washington, March
2001.
Gottlieb, Scott. “Increases in Life Expectancy likely to be Smaller in Future.” British Med-
ical Journal 3, March 2001.
Grein, Thomas W. et al. “Rumors of Disease in the Global Village: Outbreak Verifica-
tion,” Emerging Infectious Diseases 6, no. 2 (March – April 2000). Atlanta, Ga.: Centers for
Disease Control and Prevention.
Macalester International Vol. 11
22
Heymann, David I., and Guénaël R. Rodier. “Global Surveillance of Communicable Dis-
eases.” Emerging Infectious Diseases 4, no. 1 (Special Issue, January–March 1998). Atlanta,
Ga.: Centers for Disease Control and Prevention.
Kochi, Arata. “The Global Tuberculosis Situation and the New Control Strategy of the
World Health Organization.” Tubercle 72 (1–6), 1991.
The Lancet 357, no. 9269 (26 May 2001). Series of articles on World Health Report 2000. See
also, http://www.fiocruz.br/cict/dis/verbra.htm.
Olshansky, S. Jay, Bruce A. Carnes, and Robert N. Butler. “If Humans were Built to
Last.” Scientific American, March 2001.
Peterson, Peter G. Gray Dawn: How the Coming Age Wave Will Transform America—and the
World. New York: Times Books, Random House, 1999.
Quéau, Philippe. “Un Mythe Fondateur pour la Mondialisation. Le Monde, 16 February
2001.
“Le Risque Alimentaire.” La Recherche, Spécial, no. 338, February 2001.
Sachs, Jeffrey D., Andrew D. Mellinger, and John L. Gallup. “The Geography of Poverty
and Wealth.” Scientific American, March 2001.
Sharbaro, John A. “Kochi’s Tuberculosis Strategy Article is a ‘Classic’ by any Definition.”
Bulletin of the World Health Organization 79, no. 1. Geneva, 2001.
Sen, Amartya. “Women’s Agency and Social Change” (Chapter 8) and “Population,
Food and Freedom” (Chapter 9). In Development as Freedom. New York: Alfred A. Knopf,
2000.
“Sins of the Secular Missionaries.” The Economist, 29 January 2000.
Shkolnikov, Vladimir, Martin McKee, and David A. Leon. “Changes in Life Expectancy
in Russia in the mid-1990s.” The Lancet 357, Issue 9260, 24 March 2001.
Sureau, Claude. “Clonages.” Commentaire, no. 90, Summer 2000.
United Nations General Assembly. Special Session of the General Assembly on
HIV/AIDS. “Review of the Problem of Human Immunodeficiency Virus/Acquired
Immunodeficiency Syndrome in All its Aspects.” Report of the Secretary-General,
A/55/779. New York, 16 February 2001.
The World Health Organization. World Health Reports: 1995 – 2001. Geneva, Switzerland.
Hiroshi Nakajima
23
